Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05370612 · ClinicalTrials.gov registry record · NA
AT GOAL: Adopting Technology for Glucose Optimization and Lifestyle in Pregnancy
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT05370612 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 16 participants.
The verdict
NCT05370612, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This study will assess differences in patient preferences and glucose control between continuous glucose monitoring and standard glucose checks in pregnant patients with Type 2 Diabetes. 40 participants will be on study for approximately 182 days (26 weeks).
Interventions
- DEVICE Dexcom G6 CGM
- OTHER Participant Finger Stick Glucose Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2022-08-08 |
| Est. Completion | 2024-10-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05370612
The ClinicalTrials.gov registry entry for NCT05370612 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexcom G6 CGM is the first listed.
NCT05370612 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05370612 about?
NCT05370612 is a clinical study titled "AT GOAL: Adopting Technology for Glucose Optimization and Lifestyle in Pregnancy". This study will assess differences in patient preferences and glucose control between continuous glucose monitoring and standard glucose checks in pregnant patients with Type 2 Diabetes. 40 participants will be on study for approximately 182 days (26 weeks).
What is the current status of trial NCT05370612?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2022-08-08. Estimated completion is 2024-10-06.
What interventions are being tested in trial NCT05370612?
The interventions under investigation include: Dexcom G6 CGM (DEVICE), Participant Finger Stick Glucose Monitoring (OTHER).
Who is sponsoring clinical trial NCT05370612?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.